Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Feb;79(2):649–652. doi: 10.1172/JCI112862

Localization of the gene for coagulation factor XIII a-chain to chromosome 6 and identification of sites of synthesis.

L J Weisberg, D T Shiu, C S Greenberg, Y W Kan, M A Shuman
PMCID: PMC424157  PMID: 3027131

Abstract

Factor XIII, the clotting factor essential for covalent stabilization of the fibrin clot, is a heterodimer consisting of a2 and b2 subunits, with catalytic function residing in the a-chain. In order to address questions regarding sites of synthesis and chromosomal localization of the Factor XIII a-chain, cDNA was cloned from a lambda gt11 human placental cDNA library. Nucleotide and amino acid sequences were determined from the cDNA. Amino acid sequencing of purified platelet Factor XIII a-chains confirmed the authenticity of the lambda gt11 clone. The gene for Factor XIII a-chain was mapped uniquely to chromosome 6. Northern blot analysis of human placental and U937 (monocytelike) cell poly (A)+ mRNA showed a single approximately 4.0-kb message for the Factor XIII a-chain. These results provide conclusive evidence that the a-chain is synthesized by placenta and monocyte cell lines.

Full text

PDF
651

Images in this article

650Image
on p.650
651Image
on p.651

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birnboim H. C., Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 1979 Nov 24;7(6):1513–1523. doi: 10.1093/nar/7.6.1513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Board P. G., Reid M., Serjeantson S. The gene for coagulation factor XIII a subunit (F13A) is distal to HLA on chromosome 6. Hum Genet. 1984;67(4):406–408. doi: 10.1007/BF00291400. [DOI] [PubMed] [Google Scholar]
  3. Bohn H. Comparative studies on the fibrin-stabilizing factors from human plasma, platelets and placentas. Ann N Y Acad Sci. 1972 Dec 8;202:256–272. doi: 10.1111/j.1749-6632.1972.tb16339.x. [DOI] [PubMed] [Google Scholar]
  4. Cathala G., Savouret J. F., Mendez B., West B. L., Karin M., Martial J. A., Baxter J. D. A method for isolation of intact, translationally active ribonucleic acid. DNA. 1983;2(4):329–335. doi: 10.1089/dna.1983.2.329. [DOI] [PubMed] [Google Scholar]
  5. Chung S. I. Comparative studies on tissue transglutaminase and factor XIII. Ann N Y Acad Sci. 1972 Dec 8;202:240–255. doi: 10.1111/j.1749-6632.1972.tb16338.x. [DOI] [PubMed] [Google Scholar]
  6. Chung S. I., Lewis M. S., Folk J. E. Relationships of the catalytic properties of human plasma and platelet transglutaminases (activated blood coagulation factor XIII) to their subunit structures. J Biol Chem. 1974 Feb 10;249(3):940–950. [PubMed] [Google Scholar]
  7. Curtis C. G., Brown K. L., Credo R. B., Domanik R. A., Gray A., Stenberg P., Lorand L. Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor. Biochemistry. 1974 Aug 27;13(18):3774–3780. doi: 10.1021/bi00715a024. [DOI] [PubMed] [Google Scholar]
  8. Duckert F. Documentation of the plasma factor XIII deficiency in man. Ann N Y Acad Sci. 1972 Dec 8;202:190–199. doi: 10.1111/j.1749-6632.1972.tb16331.x. [DOI] [PubMed] [Google Scholar]
  9. Ebina Y., Ellis L., Jarnagin K., Edery M., Graf L., Clauser E., Ou J. H., Masiarz F., Kan Y. W., Goldfine I. D. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell. 1985 Apr;40(4):747–758. doi: 10.1016/0092-8674(85)90334-4. [DOI] [PubMed] [Google Scholar]
  10. Gaffney P. J., Whitaker A. N. Fibrin crosslinks and lysis rates. Thromb Res. 1979 Jan;14(1):85–94. doi: 10.1016/0049-3848(79)90027-6. [DOI] [PubMed] [Google Scholar]
  11. Gewirtz A. M., Burger D., Rado T. A., Benz E. J., Jr, Hoffman R. Constitutive expression of platelet glycoproteins by the human leukemia cell line K562. Blood. 1982 Sep;60(3):785–789. [PubMed] [Google Scholar]
  12. Graham J. B., Edgell C. J., Fleming H., Namboodiri K. K., Keats B. J., Elston R. C. Coagulation factor XIII: a useful polymorphic genetic marker. Hum Genet. 1984;67(2):132–135. doi: 10.1007/BF00272987. [DOI] [PubMed] [Google Scholar]
  13. Henriksson P., Becker S., Lynch G., McDonagh J. Identification of intracellular factor XIII in human monocytes and macrophages. J Clin Invest. 1985 Aug;76(2):528–534. doi: 10.1172/JCI112002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kiesselbach T. H., Wagner R. H. Demonstration of factor XIII in human megakaryocytes by a fluorescent antibody technique. Ann N Y Acad Sci. 1972 Dec 8;202:318–328. doi: 10.1111/j.1749-6632.1972.tb16344.x. [DOI] [PubMed] [Google Scholar]
  15. Lebo R. V., Gorin F., Fletterick R. J., Kao F. T., Cheung M. C., Bruce B. D., Kan Y. W. High-resolution chromosome sorting and DNA spot-blot analysis assign McArdle's syndrome to chromosome 11. Science. 1984 Jul 6;225(4657):57–59. doi: 10.1126/science.6587566. [DOI] [PubMed] [Google Scholar]
  16. Lorand L., Losowsky M. S., Miloszewski K. J. Human factor XIII: fibrin-stabilizing factor. Prog Hemost Thromb. 1980;5:245–290. [PubMed] [Google Scholar]
  17. Melton D. A., Krieg P. A., Rebagliati M. R., Maniatis T., Zinn K., Green M. R. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 1984 Sep 25;12(18):7035–7056. doi: 10.1093/nar/12.18.7035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Messing J. New M13 vectors for cloning. Methods Enzymol. 1983;101:20–78. doi: 10.1016/0076-6879(83)01005-8. [DOI] [PubMed] [Google Scholar]
  19. Olaisen B., Gedde-Dahl T., Jr, Teisberg P., Thorsby E., Siverts A., Jonassen R., Wilhelmy M. C. A structural locus for coagulation factor XIIIA (F13A) is located distal to the HLA region on chromosome 6p in man. Am J Hum Genet. 1985 Jan;37(1):215–220. [PMC free article] [PubMed] [Google Scholar]
  20. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Schwartz M. L., Pizzo S. V., Hill R. L., McKee P. A. Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. J Biol Chem. 1973 Feb 25;248(4):1395–1407. [PubMed] [Google Scholar]
  22. Schwartz M. L., Pizzo S. V., Hill R. L., McKee P. A. The subunit structures of human plasma and platelet factor XIII (fibrin-stabilizing factor). J Biol Chem. 1971 Sep 25;246(18):5851–5854. [PubMed] [Google Scholar]
  23. Shen L. L., Hermans J., McDonagh J., McDonagh R. P., Carr M. Effects of calcium ion and covalent crosslinking on formation and elasticity of fibrin cells. Thromb Res. 1975 Mar;6(3):255–265. doi: 10.1016/0049-3848(75)90073-0. [DOI] [PubMed] [Google Scholar]
  24. Tabilio A., Rosa J. P., Testa U., Kieffer N., Nurden A. T., Del Canizo M. C., Breton-Gorius J., Vainchenker W. Expression of platelet membrane glycoproteins and alpha-granule proteins by a human erythroleukemia cell line (HEL). EMBO J. 1984 Feb;3(2):453–459. doi: 10.1002/j.1460-2075.1984.tb01827.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Takagi T., Doolittle R. F. Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin. Biochemistry. 1974 Feb 12;13(4):750–756. doi: 10.1021/bi00701a018. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES